TScan Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
14.00
|
|
Average Rating
|
4.40
|
|
# Strong Buys
|
2
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.70
|
0.00
|
0.70
|
100.00%
|
|
2022-12-31
|
-0.77
|
0.00
|
0.77
|
100.00%
|
|
2022-09-30
|
-0.72
|
-0.67
|
0.05
|
6.94%
|
|
2022-06-30
|
-0.75
|
-0.63
|
0.12
|
16.00%
|
|
2022-03-31
|
-0.72
|
-0.67
|
0.05
|
6.94%
|
|
2021-12-31
|
-0.73
|
-0.38
|
0.35
|
47.95%
|
|
2021-09-30
|
-0.64
|
-0.80
|
-0.16
|
-25.00%
|
|
2021-06-30
|
-2.87
|
-7.69
|
-4.82
|
-167.94%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.97
|
|
2021-12-31
|
-9.98
|